Equifax Exceeds Q4 Revenue Expectations, Provides Strong 2026 Guidance, and Executes Substantial Share Repurchase
Summary
Equifax reported better-than-expected Q4 2025 revenue, provided strong full-year 2026 guidance, and repurchased $500 million in shares, signaling robust performance and future growth despite market headwinds.
Key Events
-
Exceeded Q4 2025 Revenue Guidance
Fourth quarter 2025 revenue reached $1.551 billion, marking a 9% increase year-over-year and exceeding the midpoint of guidance by $30 million, despite weaker U.S. hiring and mortgage markets.
-
Strong Full-Year 2026 Guidance
The company issued full-year 2026 guidance with a midpoint expectation for revenue of $6.72 billion (up 10.5%) and Adjusted EPS of $8.50 per share (up 11%), reflecting confidence in continued growth.
-
Significant Share Repurchase Program
Equifax returned $561 million of cash to shareholders in Q4 2025, including repurchasing 2.3 million shares for $500 million under its $3 billion share repurchase program.
-
Robust Free Cash Flow Generation
Full-year 2025 free cash flow increased by almost 40% to $1.13 billion, driven by strong operating performance and cash conversion.
Analysis
Equifax reported robust fourth-quarter 2025 financial results, surpassing revenue guidance and demonstrating resilience in challenging U.S. mortgage and hiring markets. The company's strong performance was driven by significant growth in U.S. Mortgage revenue and its Workforce Solutions segment. Furthermore, Equifax issued an optimistic outlook for full-year 2026, projecting double-digit growth in both revenue and Adjusted EPS. The substantial share repurchase program in Q4 underscores management's confidence and commitment to returning capital to shareholders. This positive news, released while the stock is trading near its 52-week low, could serve as a significant catalyst for investor sentiment.
At the time of this filing, EFX was trading at $178.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $21.4B. The 52-week trading range was $173.83 to $281.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.